Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
Explore the latest news and publications, innovation milestones, and drug-device insights from PARI and our pharmaceutical partners leveraging eFlow® Technology.
Recent announcements, achievements, and development milestones from PARI's pharmaceutical partners utilizing eFlow® Technology.
Santhera Announces Publication of Phase I Clinical Data with POL6014 in Journal of Cystic Fibrosis
PARI Pharma spin-out Breath Therapeutics acquired by Zambon Pharma
New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspension) in Patients with Refractory MAC Lung Disease
Sunovion to Present Data on LONHALA® MAGNAIR® Inhalation Solution and COPD at the American Thoracic Society International Conference 2019
Breath Therapeutics Announces Initiation of Global Phase 3 Trials for the Treatment of Bronchiolitis Obliterans Syndrome.